OAKTREE CAPITAL MANAGEMENT LP - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$6,088,000
-58.8%
7,114,000
-57.2%
0.11%
-59.3%
Q1 2019$14,762,000
+36.4%
16,632,000
+27.9%
0.28%
+182.8%
Q4 2018$10,820,000
+112.4%
13,000,000
+116.7%
0.10%
+43.5%
Q3 2018$5,094,000
-65.6%
6,000,000
-60.6%
0.07%
-66.7%
Q2 2018$14,796,000
+24.7%
15,230,000
+17.3%
0.21%
+10.1%
Q1 2018$11,866,000
+1.0%
12,985,000
-5.8%
0.19%
+2.2%
Q4 2017$11,743,000
-17.2%
13,785,000
-12.1%
0.18%
-13.2%
Q3 2017$14,176,000
+135.4%
15,690,000
+124.1%
0.21%
+116.3%
Q2 2017$6,021,000
-81.2%
7,000,000
-81.3%
0.10%
-78.9%
Q1 2017$31,980,000
-24.9%
37,450,000
+1.5%
0.46%
-17.3%
Q4 2015$42,596,00036,900,0000.56%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 3,586,000$3,076,0002.19%
Telemetry Investments, L.L.C. 4,000,000$3,433,0001.62%
Mohican Financial Management, LLC 1,000,000$858,0001.49%
Opera Trading Capital 5,000,000$4,276,0000.75%
SYMPHONY ASSET MANAGEMENT LLC 6,060,000$5,231,0000.59%
Castle Creek Arbitrage, LLC 6,000,000$5,153,0000.55%
SSI INVESTMENT MANAGEMENT LLC 5,683,000$4,876,0000.43%
CANYON CAPITAL ADVISORS LLC 29,000,000$24,886,0000.41%
IRON Financial LLC 470,000$404,0000.36%
Man Investments (CH) AG 600,000$515,0000.33%
View complete list of ACORDA THERAPEUTICS INC shareholders